Kymera Therapeutics' stock surged 17% after enrolling in a Phase 2b Broaden2 trial for its KT-621 drug, aimed at treating atopic dermatitis. BlackBerry's shares rose 20% following better-than-expected fiscal first-quarter results, reporting an adjusted profit of 4 cents per share on revenue of $152.9 million, surpassing analyst expectations.
Conversely, Apple saw its shares drop nearly 5% after announcing price increases for MacBooks and iPads, citing rising demand and costs for components. AeroVironment's stock fell 4% ahead of its fourth-quarter earnings report, as it prepares to restate previous results.
Microsoft shares declined 3.8% after announcing price hikes for Xbox consoles, explaining that consoles are typically sold at a loss. Hertz Global's stock dropped over 9% due to a secondary offering of 37 million shares priced at $2.70 each, with proceeds going to JPMorgan.
Micron's shares soared 15% after reporting third-quarter earnings of $25.11 per share, significantly exceeding expectations, while Qualcomm's stock gained 8% after nearly doubling its 2029 revenue forecast. Memory stocks also rose, with Sandisk up 18% and Western Digital up 7%.
Wendy's shares fell nearly 3% after a previous surge, and Trip.com shares declined almost 2% after missing earnings expectations. Bio-Techne's stock rallied 19.7% following its acquisition by Merck for $73 per share, while Dollar Tree dropped 1.6% amid a major shareholder's block trade.
McCormick reported second-quarter earnings of 80 cents per share, exceeding expectations, leading to a 4% stock gain